Wockhardt

Wockhardt shares zoom 20% on this USFDA approval

Dec 01, 2025, 12:07 PM IST

In an exchange filing, Wockhardt said: "The NDA was originally filed on September 30, 2025, and its acceptance marks a transformative moment -- not only for Wockhardt, but also for the entire Indian pharmaceutical industry."

Wockhardt shares surge 10% on Q2 earnings despite revenue dip

Nov 03, 2025, 04:55 PM IST

Wockhardt logged a 5.81% year-on-year reduction in consolidated revenue from operations, reporting Rs 762 crore in Q2FY26 against Rs 809 crore in the September quarter of the prior financial year.

US Tariffs Won’t Derail Plans For Antibiotic Zaynich: Dr Habil F Khorakiwala

Sep 26, 2025, 06:05 PM IST

In this exclusive conversation, Sakshi Batra speaks with Dr. Habil Khorakiwala, Founder Chairman of Wockhardt Group, as the company prepares to file an application for its new drug Zaynich with the USFDA next week. However, the recent imposition of 100% tariffs on certain pharma imports has created new challenges. Dr. Khorakiwala confirms that Wockhardt is not currently manufacturing in the US, but the company is exploring alternative strategies — including licensing agreements and contract manufacturing within the US — to sidestep tariff barriers without setting up a new facility. He also sheds light on the broader landscape: while Indian pharmaceutical companies dominate the generics space in the US, very few export branded drugs. Despite trade obstacles, the US remains the largest export market for Indian pharma, and Wockhardt is determined to maintain a strong presence. Additionally, Wockhardt plans to expand Zaynich into Europe and other global (ROW) markets, reinforcing its commitment to international growth. “We will find a solution,” says Dr. Khorakiwala, confidently outlining a future where strategic flexibility is key to overcoming global hurdles. Don’t miss this candid and insightful discussion on the future of Indian pharma and Wockhardt’s vision for global healthcare.

Top stocks in news: DMart, Adani Green, RITES, HCL Tech, IRB Infra, NCC, Wockhardt, BEML

Jul 14, 2025, 08:01 AM IST

Stocks including Avenue Supermarts, Adani Green Energy, RITES, HCL Tech, IRB Infra, NCC, Wockhardt, BEML, Indegene, HFCL and more will be in the spotlight on Monday, July 14.

Greaves Cotton, Paradeep Phosphates, Wockhardt shares poised for short-term gains: PL analyst

Jul 03, 2025, 06:31 PM IST

Looking ahead, select buzzing stocks like Greaves Cotton Ltd, Paradeep Phosphates Ltd and Wockhardt Ltd are expected to remain in focus among traders.

Wockhardt Q4 earnings: Net loss narrows to Rs 45 crore; revenue, EBITDA and more

May 29, 2025, 04:55 PM IST

Wockhardt reported narrowing of net loss to Rs 45 crore for Q4 FY25 compared to Rs 177 crore last year.

Stocks in news: LIC of India, Bharat Electronics, Vedanta, Glenmark Pharma, Cipla, FirstCry & NHPC

Feb 10, 2025, 07:53 AM IST

Stocks including LIC, Bharat Electronics, Vedanta, Glenmark Pharma, Cipla, FirstCry, NHPC, VA Tech Wabag and more will be in the spotlight on Monday, February 10.

Budget 2025: Pfizer, Novartis, AstraZeneca to benefit from BCD exemptions; pharma stocks mixed

Feb 01, 2025, 02:11 PM IST

Budget 2025: Select listed pharma player including Pfizer, Novartis India, AstraZeneca Pharma and GSK Pharma shall be the beneficiaries of the budget announcements.

This multibagger pharma stock jumped 9% today; stock up 10x in 21 months

Jan 03, 2025, 10:55 AM IST

Shares of Wockhardt surged 9.29 per cent to Rs 1,580 on Friday, hitting its new 52-week high. The total market capitalization of the company surged over Rs 25,000 crore for the day.

Stocks in news today: Bharti Airtel, IRFC, Varun Beverages, RITES, Biocon, NHPC & PB Fintech

Jan 03, 2025, 07:51 AM IST

Stocks including Bharti Airtel, IRFC, Varun Beverages, RITES, Biocon, NHPC, PB Fintech, Swan Energy, Wockhardt and more will be in the spotlight on Friday, January 03.

Stocks in news: Tata Steel, Power Grid, Trent, M&M, Wockhardt, Polycab & Apollo Hospitals

Nov 07, 2024, 08:17 AM IST

Stocks including Tata Steel, Power Grid, Trent, Mahindra & Mahindra, Wockhardt, Polycab India, Apollo Hospitals, Delta Corp and more will be the spotlight on Thursday, November 07.